Wellness-focused Tesamorelin programs may be discussed only after provider evaluation
3 Breakdown of the blood-brain barrier in epilepsy In earlier studies, it has been proposed that seizures disrupt the normal barrier to transport or diffusion of certain chemicals between the blood and brain tissue
The findings were similar to those against cyclophosphamide (CYP)-induced hepatorenal toxicity, whereby oral administration of VCO for 20 days alleviated lipid peroxidation, hematological alterations, oxidative stress, and hepatorenal dysfunction
Where MS Treatment Stood in the 90s23:59 - Why Early and Presymptomatic Detection Matters25:21 - Will Anti-Amyloid Drugs Be Pushed to Presymptomatic Patients?25:39 - What We Know for a Fact About Lifestyle and Disease Progression26:27 - A Real Patient Case: When to Say No to Anti-Amyloid Drugs28:30 - APOE Explained: The Gene That Changes Your Alzheimer's Risk31:49 - 3X4 Genetics: Your DNA Isn't a Verdict33:47 - How Exercise Can Offset APOE4 Risk34:10 - APOE4 Is Not Deterministic and Saying Otherwise Is Malpractice34:51 - Down Syndrome, Presenilin, and the Truly Deterministic Cases35:42 - ARIA Risk and Why Europe Restricts Anti-Amyloid Drugs for APOE4 Carriers38:00 - Where Anti-Amyloid Drugs Still Fit in Treatment39:14 - Current Clinical Trials at the Michigan Institute39:49 - Programmable Microglia: The Brain's Immune System Explained41:01 - Good Twin, Bad Twin: How Microglia Switch From Protector to Threat42:09 - Beta-Amyloid as an Antimicrobial Defender
His experience in business and product development spans over 30 years and includes a formal education in Management Information Systems and Biology at Pace University in Pleasantville, NY
